Evidence map›Paper›PMID 33807484›Full record

ArticleInternational journal of molecular sciences2021

Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations.

Lukas Schulig, Piotr Grabarczyk, Norman Geist, Martin Delin, Hannes Forkel, Martin Kulke, Mihaela Delcea, Christian A Schmidt, Andreas Link

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lukas SchuligDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-4614-3395
Piotr GrabarczykDepartment of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.
Norman GeistDepartment of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0001-9671-8882
Martin DelinDepartment of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.
Hannes ForkelDepartment of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.
Martin KulkeDepartment of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-2689-2428
Mihaela DelceaDepartment of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany.
Christian A SchmidtDepartment of Hematology and Oncology, Internal Medicine C, University Greifswald, 17489 Greifswald, Germany.
Andreas LinkDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0003-1262-6636
Universität Greifswald · DEUniversitätsmedizin Greifswald · DE

Funding

Norddeutscher Verbund für Hoch- und Höchstleistungsrechnen MVC00011
6 · The paper itself

Abstract

Transcription factors play a crucial role in regulating biological processes such as cell growth, differentiation, organ development and cellular signaling. Within this group, proteins equipped with zinc finger motifs (ZFs) represent the largest family of sequence-specific DNA-binding transcription regulators. Numerous studies have proven the fundamental role of BCL11B for a variety of tissues and organs such as central nervous system, T cells, skin, teeth, and mammary glands. In a previous work we identified a novel atypical zinc finger domain (CCHC-ZF) which serves as a dimerization interface of BCL11B. This domain and formation of the dimer were shown to be critically important for efficient regulation of the BCL11B target genes and could therefore represent a promising target for novel drug therapies. Here, we report the structural basis for BCL11B-BCL11B interaction mediated by the N-terminal ZF domain. By combining structure prediction algorithms, enhanced sampling molecular dynamics and fluorescence resonance energy transfer (FRET) approaches, we identified amino acid residues indispensable for the formation of the single ZF domain and directly involved in forming the dimer interface. These findings not only provide deep insight into how BCL11B acquires its active structure but also represent an important step towards rational design or selection of potential inhibitors.

Indexed as

Amino Acid SequenceDimerizationDNA-Binding ProteinsFluorescence Resonance Energy TransferHEK293 CellsHumansMolecular Dynamics SimulationRepressor ProteinsTranscription FactorsTumor Suppressor ProteinsZinc FingersBCL11B protein, humanDNA-Binding ProteinsRepressor ProteinsTranscription FactorsTumor Suppressor ProteinsBCL11BCCHC zinc fingerhomodimerizationprotein foldingprotein-protein dockingreplica-exchange molecular dynamicsTIGER2hTIGER2hs

Identifiers

PMID33807484
PMCPMC8036541
OpenAlexW3141855295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.